- Home
- SCVL vs ALT Comparison
SCVL vs ALT Comparison
Compare SCVL & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCVL
- ALT
- Stock Information
- Founded
- SCVL 1978
- ALT 1997
- Country
- SCVL United States
- ALT United States
- Employees
- SCVL N/A
- ALT N/A
- Industry
- SCVL Clothing/Shoe/Accessory Stores
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- SCVL Consumer Discretionary
- ALT Health Care
- Exchange
- SCVL Nasdaq
- ALT Nasdaq
- Market Cap
- SCVL 481.8M
- ALT 472.3M
- IPO Year
- SCVL 1993
- ALT N/A
- Fundamental
- Price
- SCVL $19.22
- ALT $5.40
- Analyst Decision
- SCVL Strong Buy
- ALT Strong Buy
- Analyst Count
- SCVL 1
- ALT 7
- Target Price
- SCVL $51.00
- ALT $21.00
- AVG Volume (30 Days)
- SCVL 480.4K
- ALT 2.5M
- Earning Date
- SCVL 05-30-2025
- ALT 05-13-2025
- Dividend Yield
- SCVL 3.12%
- ALT N/A
- EPS Growth
- SCVL N/A
- ALT N/A
- EPS
- SCVL 2.39
- ALT N/A
- Revenue
- SCVL $1,180,235,000.00
- ALT $20,000.00
- Revenue This Year
- SCVL $1.17
- ALT $4,108.32
- Revenue Next Year
- SCVL $4.11
- ALT $3,900.06
- P/E Ratio
- SCVL $8.04
- ALT N/A
- Revenue Growth
- SCVL N/A
- ALT N/A
- 52 Week Low
- SCVL $16.14
- ALT $3.55
- 52 Week High
- SCVL $46.92
- ALT $11.16
- Technical
- Relative Strength Index (RSI)
- SCVL 50.86
- ALT 52.71
- Support Level
- SCVL $18.13
- ALT $5.38
- Resistance Level
- SCVL $20.72
- ALT $5.81
- Average True Range (ATR)
- SCVL 0.82
- ALT 0.35
- MACD
- SCVL 0.01
- ALT -0.03
- Stochastic Oscillator
- SCVL 36.58
- ALT 34.18
About SCVL Shoe Carnival Inc.
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.